Skip to main content

Table 1 Survey-weighted baseline characteristics of obese participants (representing 64,916,705 individuals) stratified by ePWV median levels

From: Predictive value of estimated pulse wave velocity for cardiovascular and all-cause mortality in individuals with obesity

Variables

Low ePWV

(4.78–7.87 m/s)

n = 4157

High ePWV

(7.87–16.26 m/s)

n = 4158

P-value

Variables

Low ePWV

(4.78–7.87 m/s)

n = 4157

High ePWV

(7.87–16.26 m/s)

n = 4158

P-value

Represented size

35,722,926

29,193,779

 

No

2748 (98.61)

3045 (92.58)

 

BMI (kg/m2)

35.72 (0.12)

35.88 (0.13)

0.162

Yes

42 (1.39)

265 (7.42)

 

PIR

2.70 (0.05)

3.05 (0.05)

 < 0.001

Arthritis

  

 < 0.001

Waist (cm)

112.71 (0.29)

115.64 (0.30)

 < 0.001

No

3476 (83.15)

2151 (52.65)

 

HB (g/dL)

14.32 (0.04)

14.28 (0.04)

 < 0.001

Yes

677 (16.85)

1996 (47.35)

 

HBA1C (%)

5.61 (0.02)

6.09 (0.03)

 < 0.001

CKD

  

 < 0.001

FPG (mg/dL)

106.67 (0.74)

120.46 (1.62)

 < 0.001

No

3547 (91.52)

2745 (74.66)

 

AST (U/L)

26.02 (0.23)

26.60 (0.34)

0.017

Yes

380 (8.48)

1224 (26.34)

 

ALT (U/L)

30.53 (0.34)

27.29 (0.40)

 < 0.001

DM

  

 < 0.001

TB (μmol/L)

11.50 (0.12)

12.06 (0.13)

 < 0.001

No

3396 (88.34)

2584 (68.05)

 

Creatinine(μmol/L)

75.57 (0.47)

82.69 (0.56)

 < 0.001

Yes

561 (11.66)

1574 (31.95)

 

HDL (mmol/L)

1.18 (0.01)

1.27 (0.01)

 < 0.001

CVD

  

 < 0.001

TC (mmol/L)

5.05 (0.02)

5.14 (0.03)

0.011

No

3397 (96.41)

2584 (82.89)

 

LDL (mmol/L)

3.06 (0.03)

2.98 (0.03)

 < 0.001

Yes

159 (3.59)

789 (17.11)

 

TG (mmol/L)

1.66 (0.04)

1.86 (0.05)

 < 0.001

Hypertension

  

 < 0.001

CRP (mg/dL)

0.60 (0.02)

0.57 (0.02)

0.316

No

2977 (71.63)

998 (27.32)

 

Age

  

 < 0.001

Yes

1180 (28.37)

3160 (72.68)

 

  < 60 years

4133 (99.45)

1745 (51.61)

 

Hyperlipidemia

  

 < 0.001

  ≥ 60 years

24 (0.55)

2413 (48.39)

 

No

1107 (25.06)

688 (15.24)

 

Gender

  

0.529

Yes

3050 (74.94)

3470 (84.76)

 

  Women

2293 (51.90)

2265 (52.89)

 

Antihypertensive medication

  

 < 0.001

  Men

1864 (48.10)

1893 (47.11)

 

No

4000 (96.10)

3499 (85.31)

 

Race

  

 < 0.001

Yes

157 (3.90)

656 (14.69)

 

  Non-Hispanic white

1591 (59.61)

1736 (70.27)

 

Diabetes medications

  

 < 0.001

  Non-Hispanic black

1079 (15.76)

1223 (15.29)

 

No

3846 (93.21)

3113 (79.13)

 

  Mexican American

842 (13.04)

681(6.94)

 

Yes

311 (6.79)

1042 (20.87)

 

  Other races

645 (11.59)

518 (7.50)

 

Alcohol user

  

 < 0.001

Education Levels

  

 < 0.001

Never

501 (9.82)

636 (12.46)

 

  Less than 9th grade

315 (4.79)

604 (7.42)

 

Former

552 (13.02)

1081(22.74)

 

  9-11th grade/high school grade or equivalent

1691 (37.50)

1725 (39.59)

 

Mild/moderate

1034 (27.26)

1229 (34.12)

 

  College graduate or above

2146 (57.71)

1827 (52.99)

 

Heavy

1714 (42.76)

958 (25.26)

 

Marital Status

  

 < 0.001

Refused/Don't know

356 (7.14)

254 (5.41)

 

  Never married

1128 (24.23)

363 (8.28)

 

Smoke status

  

 < 0.001

  Married

2011 (53.09)

2286 (60.93)

 

Never

2546 (59.81)

2176 (51.76)

 

  Separated

163 (2.76)

156 (2.41)

 

Former

642 (17.63)

1376 (34.24)

 

  Divorced

362 (9.14)

640 (14.92)

 

Current

967 (22.56)

603 (14.0)

 

  Widowed

36 (0.63)

572 (10.28)

     

  Living with partner/others

457 (10.13)

141 (3.19)

     

Asthma

  

0.003

    

  No

3404 (81.86)

3510 (84.63)

     

  Yes

747 (18.14)

646 (15.37)

     

Osteoporosis

  

 < 0.001

    
  1. Continuous variables are expressed as weighted mean (Standard error, SE). Categorical variables are expressed as counts (weighted %)
  2. ePWV estimated pulse wave velocity, CVD cardiovascular diseases, PIR Poverty income ratio, CKD Chronic kidney disease, BMI body mass index, HB hemoglobin, FPG fasting plasma glucose, TB Total bilirubin, TC Total cholesterol, LDL low-density lipoprotein cholesterol, TG triglycerides, HDL high-density lipoprotein cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, HbA1C glycated hemoglobinA1c